Literature DB >> 14552781

Aryl piperazine melanocortin MC4 receptor agonists.

Brian Dyck1, Jessica Parker, Teresa Phillips, Lee Carter, Brian Murphy, Robin Summers, Julia Hermann, Tracy Baker, Mary Cismowski, John Saunders, Val Goodfellow.   

Abstract

Incorporation of substituted phenyl piperazine privileged structures into a known MC4 specific dipeptoid consensus sequence resulted in a series of potent (EC(50)=24 nM) and selective MC4-R agonists. We report the SAR of this series of compounds using in vitro cAMP functional assays in cells transfected with the MC4 or other melancortin receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14552781     DOI: 10.1016/s0960-894x(03)00796-0

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Interactions of human melanocortin 4 receptor with nonpeptide and peptide agonists.

Authors:  Irina D Pogozheva; Biao-Xin Chai; Andrei L Lomize; Tung M Fong; David H Weinberg; Ravi P Nargund; Michael W Mulholland; Ira Gantz; Henry I Mosberg
Journal:  Biochemistry       Date:  2005-08-30       Impact factor: 3.162

Review 2.  Design, synthesis and biological evaluation of ligands selective for the melanocortin-3 receptor.

Authors:  Victor J Hruby; Minying Cai; James P Cain; Alexander V Mayorov; Matthew M Dedek; Devendra Trivedi
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

3.  Synthesis of Pyrimidine Incorporated Piperazine Derivatives and their Antimicrobial Activity.

Authors:  K S Thriveni; B Padmashali; M B Siddesh; C Sandeep
Journal:  Indian J Pharm Sci       Date:  2014-07       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.